Media Coverage

Quest Diagnostics recently surveyed over 500 physicians in coordination with The Harris Poll to uncover attitudes about the rising drug overdose crisis and the role of clinical drug testing in safely prescribing opioids. A key theme emerged from the findings: physicians believe clinical drug testing is critical for managing opioids and other prescribed controlled medications, but feel clearer guidelines are needed to help optimize its use.

Diabetic retinopathy is the leading cause of blindness in the U.S., according to the Centers for Disease Control and Prevention. Now, an expanded collaboration between Quest Diagnostics and IRIS (Intelligent Retinal Imaging Systems) aims to increase convenience and improve screening rates for this condition.

As society begins to open back up again, we wanted to know your thoughts on health care and what you personally need to live fully. So together with QuestDirect™—a service from Quest Diagnostics® that makes it easy to buy lab tests online for at-home or in-person collection without visiting a doctor first—we asked Well+Good readers in a survey, and over 1,400 of you responded.

Working Americans tested positive for drugs last year at the highest rate in more than two decades, mostly due to an increase in positive marijuana tests, according to research from Quest Diagnostics.

Allergy responses start because you've come in contact with allergens, but a lot of them might be invisible to you, says Harvey Kaufman, MD, senior medical director at Quest Diagnostics, with a specialization in allergy testing. "Understanding the cause of your allergies and identifying sensitivity plays a pivotal role in managing seasonal allergies," Dr. Kaufman says.

Positive drug tests among U.S. workers hit the highest level since 2001 last year, according to an analysis released Wednesday by Quest Diagnostics, one of the largest drug-testing laboratories in the country.

The percentage of working Americans testing positive for drugs hit a two-decade high last year, driven by an increase in positive marijuana tests, as businesses might have loosened screening policies amid nationwide labor shortages. Of the more than six million general workforce urine tests that Quest Diagnostics Inc., one of the country’s largest drug-testing laboratories, screened for marijuana last year, 3.9% came back positive, an increase of more than 8% from 2020, according to Quest’s annual drug-testing index.

COVID-19 mandates in the U.S. are loosening or in some cases the restrictions are being eliminated. However, one thing that remains strong is the desire to understand more about the respiratory disease, which is caused by the SARS-CoV-2. To that end, the Centers of Disease and Control and Prevention has contracted Quest Diagnostics to employ a comprehensive menu of COVID-19 antibody tests and data analytics services to research the disease. Quest won the $19.5 million contract in a competitive bid.

The Quest Diagnostics Foundation has donated $500,000 to Project Health Opportunities for People Everywhere (HOPE) to aid humanitarian crisis relief for Ukraine and for Ukrainian refugees in Eastern Europe.

The Covid-19 pandemic has hastened consumers’ willingness to test for more medical conditions at home, test makers said, expanding the market for self-diagnostic products. Manufacturers are developing new types of at-home tests, including for flu and strep throat, aimed at consumers who are increasingly monitoring and managing their own health through fitness apps and smartwatches. Cathy Doherty, an executive at Quest in charge of the consumer-testing business, said Quest’s research shows that consumers are interested in a wider range of at-home tests, but many still prefer visiting a doctor’s office or testing center to make sure the tests are performed correctly.